197 related articles for article (PubMed ID: 26937631)
21. Clinical outcome with correlation to disseminated tumor cell (DTC) status after DTC-guided secondary adjuvant treatment with docetaxel in early breast cancer.
Naume B; Synnestvedt M; Falk RS; Wiedswang G; Weyde K; Risberg T; Kersten C; Mjaaland I; Vindi L; Sommer HH; Sætersdal AB; Rypdal MC; Bendigtsen Schirmer C; Wist EA; Borgen E
J Clin Oncol; 2014 Dec; 32(34):3848-57. PubMed ID: 25366688
[TBL] [Abstract][Full Text] [Related]
22. Does primary neoadjuvant systemic therapy eradicate minimal residual disease? Analysis of disseminated and circulating tumor cells before and after therapy.
Kasimir-Bauer S; Bittner AK; König L; Reiter K; Keller T; Kimmig R; Hoffmann O
Breast Cancer Res; 2016 Feb; 18(1):20. PubMed ID: 26868521
[TBL] [Abstract][Full Text] [Related]
23. A high-risk 70-gene signature is not associated with the detection of tumor cell dissemination to the bone marrow.
Walter VP; Taran FA; Wallwiener M; Walter C; Grischke EM; Wallwiener D; Brucker SY; Hartkopf AD
Breast Cancer Res Treat; 2018 Jun; 169(2):305-309. PubMed ID: 29374853
[TBL] [Abstract][Full Text] [Related]
24. Prognostic relevance of disseminated tumor cells in the bone marrow and biological factors of 265 primary breast carcinomas.
Schindlbeck C; Kampik T; Janni W; Rack B; Jeschke U; Krajewski S; Sommer H; Friese K
Breast Cancer Res; 2005; 7(6):R1174-85. PubMed ID: 16457698
[TBL] [Abstract][Full Text] [Related]
25. Trastuzumab clears HER2/neu-positive isolated tumor cells from bone marrow in primary breast cancer patients.
Rack B; Jückstock J; Günthner-Biller M; Andergassen U; Neugebauer J; Hepp P; Schoberth A; Mayr D; Zwingers T; Schindlbeck C; Friese K; Janni W
Arch Gynecol Obstet; 2012 Feb; 285(2):485-92. PubMed ID: 21717141
[TBL] [Abstract][Full Text] [Related]
26. Analysis of and prognostic information from disseminated tumour cells in bone marrow in primary breast cancer: a prospective observational study.
Falck AK; Bendahl PO; Ingvar C; Isola J; Jönsson PE; Lindblom P; Lövgren K; Rennstam K; Fernö M; Rydén L
BMC Cancer; 2012 Sep; 12():403. PubMed ID: 22963449
[TBL] [Abstract][Full Text] [Related]
27. DTCs in breast cancer: clinical research and practice.
Janni W; Rack B; Kasprowicz N; Scholz C; Hepp P
Recent Results Cancer Res; 2012; 195():173-8. PubMed ID: 22527504
[TBL] [Abstract][Full Text] [Related]
28. Impaired bone microenvironment: correlation between bone density and presence of disseminated tumor cells.
Kraemer B; Rothmund R; Banys M; Krawczyk N; Solomayer EF; Mack C; Wallwiener D; Fehm T
Anticancer Res; 2011 Dec; 31(12):4423-8. PubMed ID: 22199310
[TBL] [Abstract][Full Text] [Related]
29. Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients.
Pestrin M; Bessi S; Galardi F; Truglia M; Biggeri A; Biagioni C; Cappadona S; Biganzoli L; Giannini A; Di Leo A
Breast Cancer Res Treat; 2009 Dec; 118(3):523-30. PubMed ID: 19597704
[TBL] [Abstract][Full Text] [Related]
30. Disseminated tumor cells in the bone marrow of patients with ductal carcinoma in situ.
Sänger N; Effenberger KE; Riethdorf S; Van Haasteren V; Gauwerky J; Wiegratz I; Strebhardt K; Kaufmann M; Pantel K
Int J Cancer; 2011 Nov; 129(10):2522-6. PubMed ID: 21207426
[TBL] [Abstract][Full Text] [Related]
31. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization.
Riethdorf S; Pantel K
Pathobiology; 2008; 75(2):140-8. PubMed ID: 18544969
[TBL] [Abstract][Full Text] [Related]
32. Prognostic relevance of circulating tumor cells in blood and disseminated tumor cells in bone marrow of patients with squamous cell carcinoma of the oral cavity.
Gröbe A; Blessmann M; Hanken H; Friedrich RE; Schön G; Wikner J; Effenberger KE; Kluwe L; Heiland M; Pantel K; Riethdorf S
Clin Cancer Res; 2014 Jan; 20(2):425-33. PubMed ID: 24218516
[TBL] [Abstract][Full Text] [Related]
33. Detection and prevalence of disseminated tumor cells from the bone marrow of early stage male breast cancer patients.
Hartkopf AD; Taran FA; Walter CB; Hahn M; Fehm T; Wallwiener M; Brucker SY
Breast Cancer Res Treat; 2015 Jul; 152(1):51-55. PubMed ID: 26012646
[TBL] [Abstract][Full Text] [Related]
34. Different prognostic value of circulating and disseminated tumor cells in primary breast cancer: Influence of bisphosphonate intake?
Kasimir-Bauer S; Reiter K; Aktas B; Bittner AK; Weber S; Keller T; Kimmig R; Hoffmann O
Sci Rep; 2016 May; 6():26355. PubMed ID: 27212060
[TBL] [Abstract][Full Text] [Related]
35. Are disseminated tumor cells in bone marrow and tumor-stroma ratio clinically applicable for patients undergoing surgical resection of primary colorectal cancer? The Leiden MRD study.
Vogelaar FJ; van Pelt GW; van Leeuwen AM; Willems JM; Tollenaar RA; Liefers GJ; Mesker WE
Cell Oncol (Dordr); 2016 Dec; 39(6):537-544. PubMed ID: 27613548
[TBL] [Abstract][Full Text] [Related]
36. Detection of disseminated tumor cells in the bone marrow of breast cancer patients using multiplex gene expression measurements identifies new therapeutic targets in patients at high risk for the development of metastatic disease.
Siddappa CM; Watson MA; Pillai SG; Trinkaus K; Fleming T; Aft R
Breast Cancer Res Treat; 2013 Jan; 137(1):45-56. PubMed ID: 23129172
[TBL] [Abstract][Full Text] [Related]
37. Tumor cell dissemination to the bone marrow and blood is associated with poor outcome in patients with metastatic breast cancer.
Hartkopf AD; Stefanescu D; Wallwiener M; Hahn M; Becker S; Solomayer EF; Fehm TN; Brucker SY; Taran FA
Breast Cancer Res Treat; 2014 Sep; 147(2):345-51. PubMed ID: 25151295
[TBL] [Abstract][Full Text] [Related]
38. Single cell mutational analysis of PIK3CA in circulating tumor cells and metastases in breast cancer reveals heterogeneity, discordance, and mutation persistence in cultured disseminated tumor cells from bone marrow.
Deng G; Krishnakumar S; Powell AA; Zhang H; Mindrinos MN; Telli ML; Davis RW; Jeffrey SS
BMC Cancer; 2014 Jun; 14():456. PubMed ID: 24947048
[TBL] [Abstract][Full Text] [Related]
39. Immunomagnetic enrichment of disseminated tumor cells in bone marrow and blood of breast cancer patients by the Thomsen-Friedenreich-Antigen.
Schindlbeck C; Stellwagen J; Jeschke U; Karsten U; Rack B; Janni W; Jückstock J; Tulusan A; Sommer H; Friese K
Clin Exp Metastasis; 2008; 25(3):233-40. PubMed ID: 18185913
[TBL] [Abstract][Full Text] [Related]
40. Prevalence and prognostic value of disseminated tumor cells in primary endometrial, cervical and vulvar cancer patients.
Walter CB; Taran FA; Wallwiener M; Rothmund R; Kraemer B; Krawczyk N; Blassl C; Melcher C; Wallwiener D; Fehm T; Hartkopf AD
Future Oncol; 2014 Jan; 10(1):41-8. PubMed ID: 24328408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
